03
Feb

Fast on the heels of two big biotech IPOs at the end of last week, Renaissance Capital is tracking 9 more life sciences companies looking to go public this week in a fresh burst of new offerings that could threaten to glut the market. Altogether, the developers have set their sights on raising roughly $500 million in a matter of days.

…read more

Source: Eager biotechs crowd into Wall Street this week with $500M in IPO pitches

    

0 No comments